<DOC>
	<DOCNO>NCT02485028</DOCNO>
	<brief_summary>Healthy male volunteer administer alone combination dapoxetine 30mg mirodenafil 50mg three time , respectively pharmacokinetic interaction compare two drug .</brief_summary>
	<brief_title>Pharmacokinetic Interaction Study Dapoxetine 30mg Mirodenafil 50mg</brief_title>
	<detailed_description />
	<mesh_term>Mirodenafil</mesh_term>
	<criteria>Healthy male adult age 19 55 Body mass index ( BMI ) range 19 27 kg/m2 Understand requirement study voluntarily consent participate study Available entire study period Subject history liver disease , kidney , digestive system , respiratory system , endocrine system , nervous psychiatric , blood , cancer , cardiovascular disease Subject clinically significant vital sign ( sit position blood pressure ) ( 90 mmHg &gt; systolic blood pressure ≥ 140 mmHg , 60 mmHg &gt; diastolic blood pressure ≥ 90 mmHg ) History drug abuse History caffeine , alcohol , smoke abuse caffeine ( coffee , tea , coke ) &gt; 4cups/day smoking &gt; 10 cigarettes/day alcohol &gt; 140g/week Consumption grapefruit grapefruitcontaining juice 1 cup day Previously donate whole blood within 60 day component blood within 30 day Subject take drug affect ADME investigational product Subject know hypersensitivity reaction mirodenafil/ dapoxetine drug Inadequate laboratory test result : AST ( SGOT ) ALT ( SGPT ) total bilirubin &gt; 1.5 x upper limit normal range eGFR &lt; low limit normal range Subject consider unsuitable base medical judgement investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Dapoxetine</keyword>
	<keyword>Mirodenafil</keyword>
	<keyword>DDI study</keyword>
</DOC>